Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...
Angiotensinogen is the sole precursor of angiotensin peptides and has a key role in the pathogenesis of hypertension. Zilebesiran, an investigational RNA interference therapeutic agent with a ...
Cost-effectiveness of NALIRIFOX compared to other first-line treatments for metastatic pancreatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...
Use of the antihypertensive medications improved survival whether or not patients fully recovered from acute kidney injury. Initiating or resuming renin-angiotensin-aldosterone system (RAAS) blockade ...
At one time, dual RAAS blockade was expected to provide more-complete inhibition of RAAS among patients with DKD. Results of large clinical trials dashed these hopes, finding increased risk of AKI and ...
Investigators found no definitive benefit of dual RAAS blockade in preventing kidney failure in patients with ADPKD. For patients with autosomal dominant polycystic kidney disease (ADPKD), intensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results